SO vs TRDA · P/E 22, rev $29.55B vs P/E 12, rev $210.8M
Southern Company (SO) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
SO currently screens at market cap $101.55B and trailing P/E 22.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the SO and TRDA stock pages for the full models.
Not investment advice.